RecruitingPhase 3NCT03770923
Effect of Some Drugs on Rheumatoid Arithritis Activity
Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis
Sponsor
Sherief Abd-Elsalam
Enrollment
75 participants
Start Date
Oct 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Effect of Some Drugs on Rheumatoid Arithritis Activity.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Rheumatoid arthritis
Exclusion Criteria1
- liver or renal disease
Interventions
DRUGRupatadine
Rupatadine 10 mg daily
DRUGMontelukast
Montelukast 10 mg daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03770923
Related Trials
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
NCT0710093829 locations
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
NCT068415621 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
Biobank for Inflammatory Chronic Diseases and Osteoporosis
NCT050392161 location
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT0691680633 locations